Pharmacology, Toxicology and Pharmaceutical Science
Blood Clotting Factor 7
100%
Thromboplastin
56%
Heparin
50%
Blood Clotting Factor 9
50%
Celiac Disease
50%
Hemoglobin
50%
Triptorelin
50%
Tissue Factor Pathway Inhibitor
50%
Nitrite
50%
Thalassemia
50%
Antithrombin
50%
Coagulating Agent
50%
Autoimmune Hemolytic Anemia
50%
Site-Directed Mutagenesis
50%
Nitric Oxide
42%
Protein S
33%
Enzyme Precursor
25%
Hemophilia B
25%
Thrombogenicity
25%
Mutagenesis
18%
Hypercoagulability
16%
Local Anesthetic Agent
14%
High Density Lipoprotein 2
12%
High Density Lipoprotein 3
12%
Hemophilia A
12%
Hemostatic Agent
12%
Clotting Time
12%
Rabies Vaccine
10%
Clinical Trial
10%
Infection
10%
Vitamin Deficiency
8%
Standardized Incidence Ratio
8%
Blood Clotting Factor
8%
Cohort Study
8%
Hemolysis
7%
Lactate Dehydrogenase
7%
Monotherapy
7%
Bioavailability
7%
Hemoglobin E
7%
Lipid
7%
Endothelial Dysfunction
7%
Anion
7%
Lipid Hydroperoxide
6%
Alanine
6%
Biochemistry, Genetics and Molecular Biology
Exosite
87%
Antithrombin
53%
C1-Inhibitor
50%
Factor IX
50%
Heparin
50%
Protein C
50%
Protein C Deficiency
50%
Thrombin
25%
Wild Type
25%
Hereditary Angioedema
18%
Haemophilia B
12%
Tissue Factor Pathway Inhibitor
12%
Mutagenesis
6%
Protease
6%
Alanine
6%
Heparan Sulfate
6%
Protein
6%
Medicine and Dentistry
Systematic Review
50%
Hormonal Contraception
50%
Venous Thromboembolism
50%
Evans Syndrome
50%
Meta-Analysis
50%
Blood Clotting Factor 7 Deficiency
50%
F Factor
37%
Inpatient
16%
Activated Protein C
16%
Tissue Factor Pathway Inhibitor
16%
Patient
16%
Fibrin Formation
12%
Analysis
8%
Odds Ratio
8%
Activated Protein C Resistance
8%
Observational Study
8%
Cohort Analysis
8%
Hazard Ratio
8%
Cross Sectional Study
8%
Heat Sensation
7%
Refractory Period
7%
Topical Anesthesia
7%
Heparan Sulfate
6%
